Florida Cancer Specialists & Research Institute provides the newest cancer therapies, some not yet available elsewhere, through convenient access to clinical trials.
The survival rate for Americans diagnosed with several of the most common cancers has increased dramatically in the past nearly 3 decades, thanks in large part to scientific discoveries and treatment advances. Florida Cancer Specialists & Research Institute (FCS) physicians and patients are part of these leading-edge cancer innovations, providing the newest cancer therapies, some not yet available elsewhere, through convenient access to clinical trials.
This is possible through FCS' long-standing partnership with Sarah Cannon—a trusted expert in the field of oncology research having conducted more than 500 first-in-human trials and been a clinical trial leader in the majority of approved cancer therapies over the last decade.
Since the inception of our research program, 10,000 patients have participated in innovative studies.
Contributor: The Diabetes Vendor Resource Guide—A Useful Directory for Employers
November 13th 2024Employees living with diabetes often face unique challenges, such as managing blood sugar levels, balancing medication, and preventing complications, all while maintaining their professional responsibilities. This condition can lead to increased absenteeism, reduced productivity, and rising health care costs.
Read More